Belite Bio (BLTE) Return on Assets (2023 - 2026)
Belite Bio (BLTE) recorded quarterly Return on Assets of 0.8% in Q1 2026, up 33.21% quarter-over-quarter from 1.19% in Q4 2025, and up 99.0% on a YoY basis from 0.4% in Q1 2025.
Belite Bio (BLTE) Return on Assets (2023 - 2026) Analysis & Trends
Belite Bio's Return on Assets history runs 4 years deep, the most recent figure standing at 0.8% for Q1 2026.
- In Q1 2026, Return on Assets rose 99.0% year-over-year to 0.8%; the TTM figure through Mar 2026 stood at 0.8% (up 99.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets was 0.8% for Q1 2026 at Belite Bio, up from 1.19% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.8% in Q1 2026 to a low of 3.21% in Q2 2023.
- Historically, Return on Assets has averaged 2.02% across 4 years, with a median of 2.19% in 2025.
- Biggest YoY gain for Return on Assets was 162 bps in 2024; the steepest drop was 89 bps in 2024.
- A 4-year view of Return on Assets shows it stood at 1.8% in 2023, then tumbled by 50 bps to 2.7% in 2024, then jumped by 56 bps to 1.19% in 2025, then jumped by 33 bps to 0.8% in 2026.
- The last three Return on Assets figures came in at 0.8% (Q1 2026), 1.19% (Q4 2025), and 2.19% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -0.01% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.01% |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.80% |
| Dec 31, 2025 | -1.19% |
| Sep 30, 2025 | -2.19% |
| Jun 30, 2025 | -2.19% |
| Mar 31, 2025 | -1.79% |
| Dec 31, 2024 | -2.70% |
| Sep 30, 2024 | -2.22% |
| Jun 30, 2024 | -1.58% |
| Mar 31, 2024 | -1.50% |
| Dec 31, 2023 | -1.80% |
| Sep 30, 2023 | -2.32% |
| Jun 30, 2023 | -3.21% |
| Mar 31, 2023 | -2.78% |